agentes para o tratamento da artrite gotosa, uma vez que possui ambas as propriedades. anti-hiperuricêmica e anti-inflamatória. O extrato etanólico bruto e. Revisão crítica do tratamento medicamentoso da gota no Brasil tratamento da hiperuricemia e da artrite gotosa e especialmente para. Os objetivos principais do tratamento da tuberculose são curar o paciente e .. Artrite gotosa aguda: É rara, exceto em pacientes que apresentam história.

Author: Gardat Tagal
Country: Paraguay
Language: English (Spanish)
Genre: Finance
Published (Last): 19 May 2013
Pages: 381
PDF File Size: 3.14 Mb
ePub File Size: 1.41 Mb
ISBN: 962-1-64976-652-4
Downloads: 54267
Price: Free* [*Free Regsitration Required]
Uploader: Samukree

Services on Demand Journal.

Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: Programa Nacional de Controle da Tuberculose. World Health Organization; The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Isoniazid-induced hyperacute liver failure in a young patient receiving carbamazepine.

The magic bullets and tuberculosis drug targets. Transfer of drugs and other chemicals into human milk. Relationship with rifampicin therapy in two cases [Article in French].

Zhang Y, Yew WW. Expert Opin Drug Saf. Associada a rifampicina, pode levar a uma hepatite medicamentosa aguda e fulminante, tratamenfo rara.


artrite gotosa ou gota: by Amanda Morais on Prezi

Adverse effects of tuberculosis treatment: Ramaswamy S, Musser JM. A prospective study of hepatitis during antituberculous treatment in Taiwanese patients and a review of the literature.

N Engl J Med. Handbook of Anti-Tuberculosis Agents.

There was a problem providing the content you requested

Med Clin North Am. Update on rifampin and rifabutin tratakento interactions. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: Tuberculosis and diabetes mellitus: The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection.

The use of potentially hepatotoxic drugs in patients with liver disease. How to cite this article. A nova diretriz para o tratamento da tuberculose no Brasil 1,2 preconiza a dose de 1. Int J Tuberc Lung Dis. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Pode ser devido ao uso de rifampicina ou ter sido produzido por outro medicamento associado. Clinically significant interactions with drugs used in the treatment of tuberculosis. Mechanisms of drug resistance in Mycobacterium tuberculosis.


Am J Med Sci. SCS Quadra 1, Bl. Adverse reactions to firstline antituberculosis drugs. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.

Risk factors for sideeffects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.

Role of reactive metabolites in drug-induced hepatotoxicity. Guidelines for National Programmes.

Moreira Jr Editora | RBM Revista Brasileira de Medicina

Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients. A OMS considera o seu uso seguro. Alertar o paciente quanto a esta possibilidade.